-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Coherus BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2014 to Q3 2025.
- Coherus BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3.39M, a 50.7% decline year-over-year.
- Coherus BioSciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $20.6M, a 36.2% decline year-over-year.
- Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $27.8M, a 35.5% decline from 2023.
- Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1M, a 15% decline from 2022.
- Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $50.7M, a 1.22% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)